Around the Net

Ketamine Variant Could Be Used To Treat Depression

Esketamine, developed by Johnson & Johnson, is a nasal spray that delivers the active ingredients of ketamine, a recreational drug from the 1980s and 1990s. It could be a new treatment for severe depression and suicidal ideation after an expert panel recommended that federal regulators approve it. “The Food and Drug Administration typically follows the recommendations of its expert panels,” according to The New York Times.

Read the whole story at New York Times »

Next story loading loading..